Nobleza, Jocelyn .

HRN: 28-01-46  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/28/2025
10/31/2025
IV
900 Mg
Every 8 Hours
S/P NSVD Via Non-institutional Delivery; Retained Placenta
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: